Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test
PR Newswire•05/08/2026•08:46 ET
0
Whiz Insights
Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test
Concert's policy recognizes EsoGuard (®) as the only esophageal precancer test meeting its coverage criteria
Get started
Create a free account to read the full story.